Subspecialties: Page 1291

Boston Scientific, Guidant deal gets shareholder nod
By AuntMinnie.com staff writers
Interventional device firms Boston Scientific and Guidant said that shareholders of each company have voted to approve their merger.
April 2, 2006
CEUS aids differentiation of small liver lesions
By Erik L. Ridley
Contrast-enhanced ultrasound (CEUS) can help diagnose indeterminate small hepatic lesions, according to researchers from the University of California, San Diego. They conducted a study to assess CEUS' accuracy and role in diagnosing small lesions that were indeterminate on CT and/or MRI, and presented their findings at the recent American Institute of Ultrasound in Medicine (AIUM) meeting.
April 2, 2006
Sectra unveils new orthopedic PACS version
By AuntMinnie.com staff writers
Swedish PACS vendor Sectra has released a new version of its orthopedic PACS software.
March 30, 2006
Cardinal debuts Vertebrex
By AuntMinnie.com staff writers
Healthcare products firm Cardinal Health has introduced its Vertebrex system, which is designed for treatment of vertebral compression fractures.
March 30, 2006
Elekta buys BMEI
By AuntMinnie.com staff writers
Swedish radiation oncology firm Elekta of Stockholm has inked a deal to buy 80% of the equity of Chinese radiation therapy equipment supplier BMEI.
March 30, 2006
OnCURE buys four Florida centers
By AuntMinnie.com staff writers
Outpatient radiation therapy provider OnCURE Medical of Newport Beach, CA, has expanded its operations in Florida by acquiring four cancer therapy centers.
March 30, 2006
ART launches preclinical imaging agents
By AuntMinnie.com staff writers
Canadian optical molecular imaging developer ART Advanced Research Technologies launched a new line of biomarker products, called Fenestra, at the American Association for Cancer Research (AACR) meeting in Washington, DC, this week.
March 30, 2006
CEUS outshines three-phase CT in assessing HCC TACE response
By Erik L. Ridley
Contrast-enhanced ultrasound (CEUS) is more sensitive than three-phase CT in depicting vascularity in hepatocellular carcinomas (HCCs) treated with transcatheter arterial chemoembolization (TACE), according to an article in the April 2006 Journal of Ultrasound in Medicine.
March 30, 2006
Radiation experiment demonstrates long-term damage to normal tissue
By Shalmali Pal
By selectively irradiating blood vessels, Massachusetts Institute of Technology (MIT) researchers have ascertained at what point healthy tissue starts to degrade after radiation exposure. Their results have implications for radiation therapy and exposure, as well as for the long-term effects of both, the authors said.
March 30, 2006
Plain x-rays not recommended for confirming osteoarthritis
By Shalmali Pal
Among rheumatologists, osteoarthritis (OA) is gaining acceptance as a multisymptom disorder that ultimately leads to a similar clinical and pathological end point. But questions remain as to the role that imaging plays in tracking OA. Although plain radiography has been the primary diagnostic modality for OA for many decades, its routine use in OA patients is not indicated, according to one arthritis imaging expert.
March 30, 2006
2006 03 27 11 15 31 706
Siemens gets clearance for Axiom upgrades
By AuntMinnie.com staff writers
Multimodality vendor Siemens Medical Solutions of Malvern, PA, has received U.S. Food and Drug Administration 510(k) clearance for a pair of new technologies for its Axiom vascular imaging systems.
March 29, 2006
Limiting scan range cuts dose, boosts throughput in melanoma PET/CT
By Jonathan S. Batchelor
ORLANDO, FL - The current PET/CT protocol of scanning all melanoma patients from the crown of the head to the soles of the feet, including dedicated brain studies, may be providing little clinical value and putting patients on the gantry longer than needed, according to a study from the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).
March 29, 2006
Previous Page
Page 1291 of 1583
Next Page